238 related articles for article (PubMed ID: 32552681)
1. Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.
Vallabh SM; Minikel EV; Williams VJ; Carlyle BC; McManus AJ; Wennick CD; Bolling A; Trombetta BA; Urick D; Nobuhara CK; Gerber J; Duddy H; Lachmann I; Stehmann C; Collins SJ; Blennow K; Zetterberg H; Arnold SE
BMC Med; 2020 Jun; 18(1):140. PubMed ID: 32552681
[TBL] [Abstract][Full Text] [Related]
2. Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.
Vallabh SM; Mortberg MA; Allen SW; Kupferschmid AC; Kivisakk P; Hammerschlag BL; Bolling A; Trombetta BA; Devitte-McKee K; Ford AM; Sather LE; Duffy G; Rivera A; Gerber J; McManus AJ; Minikel EV; Arnold SE
Neurology; 2024 Jul; 103(2):e209506. PubMed ID: 38896810
[TBL] [Abstract][Full Text] [Related]
3. Biomarker changes preceding symptom onset in genetic prion disease.
Vallabh SM; Mortberg MA; Allen SW; Kupferschmid AC; Kivisäkk P; Hammerschlag BL; Bolling A; Trombetta BA; Devitte-McKee K; Ford AM; Sather L; Duffy G; Rivera A; Gerber J; McManus AJ; Minikel EV; Arnold SE
medRxiv; 2023 Dec; ():. PubMed ID: 38196583
[TBL] [Abstract][Full Text] [Related]
4. Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Mok TH; Nihat A; Majbour N; Sequeira D; Holm-Mercer L; Coysh T; Darwent L; Batchelor M; Groveman BR; Orr CD; Hughson AG; Heslegrave A; Laban R; Veleva E; Paterson RW; Keshavan A; Schott JM; Swift IJ; Heller C; Rohrer JD; Gerhard A; Butler C; Rowe JB; Masellis M; Chapman M; Lunn MP; Bieschke J; Jackson GS; Zetterberg H; Caughey B; Rudge P; Collinge J; Mead S
Brain; 2023 Jun; 146(6):2570-2583. PubMed ID: 36975162
[TBL] [Abstract][Full Text] [Related]
5. Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases.
Llorens F; Villar-Piqué A; Schmitz M; Diaz-Lucena D; Wohlhage M; Hermann P; Goebel S; Schmidt I; Glatzel M; Hauw JJ; Sikorska B; Liberski PP; Riggert J; Ferrer I; Zerr I
Neuropathol Appl Neurobiol; 2020 Apr; 46(3):240-254. PubMed ID: 31216593
[TBL] [Abstract][Full Text] [Related]
6. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease.
Abu-Rumeileh S; Baiardi S; Ladogana A; Zenesini C; Bartoletti-Stella A; Poleggi A; Mammana A; Polischi B; Pocchiari M; Capellari S; Parchi P
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1181-1188. PubMed ID: 32928934
[TBL] [Abstract][Full Text] [Related]
7. Review: Fluid biomarkers in the human prion diseases.
Thompson AGB; Mead SH
Mol Cell Neurosci; 2019 Jun; 97():81-92. PubMed ID: 30529227
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid.
Foutz A; Appleby BS; Hamlin C; Liu X; Yang S; Cohen Y; Chen W; Blevins J; Fausett C; Wang H; Gambetti P; Zhang S; Hughson A; Tatsuoka C; Schonberger LB; Cohen ML; Caughey B; Safar JG
Ann Neurol; 2017 Jan; 81(1):79-92. PubMed ID: 27893164
[TBL] [Abstract][Full Text] [Related]
9. Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases.
Zhang W; Orrú CD; Foutz A; Ding M; Yuan J; Shah SZA; Zhang J; Kotobelli K; Gerasimenko M; Gilliland T; Chen W; Tang M; Cohen M; Safar J; Xu B; Hong DJ; Cui L; Hughson AG; Schonberger LB; Tatsuoka C; Chen SG; Greenlee JJ; Wang Z; Appleby BS; Caughey B; Zou WQ
Acta Neuropathol; 2024 Jan; 147(1):17. PubMed ID: 38231266
[TBL] [Abstract][Full Text] [Related]
10. Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.
Vallabh SM; Nobuhara CK; Llorens F; Zerr I; Parchi P; Capellari S; Kuhn E; Klickstein J; Safar JG; Nery FC; Swoboda KJ; Geschwind MD; Zetterberg H; Arnold SE; Minikel EV; Schreiber SL
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7793-7798. PubMed ID: 30936307
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.
Villar-Piqué A; Schmitz M; Lachmann I; Karch A; Calero O; Stehmann C; Sarros S; Ladogana A; Poleggi A; Santana I; Ferrer I; Mitrova E; Žáková D; Pocchiari M; Baldeiras I; Calero M; Collins SJ; Geschwind MD; Sánchez-Valle R; Zerr I; Llorens F
Mol Neurobiol; 2019 Apr; 56(4):2811-2821. PubMed ID: 30062673
[TBL] [Abstract][Full Text] [Related]
12. A case report of genetic prion disease with two different PRNP variants.
Piazza M; Prior TW; Khalsa PS; Appleby B
Mol Genet Genomic Med; 2020 Mar; 8(3):e1134. PubMed ID: 31953922
[TBL] [Abstract][Full Text] [Related]
13. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
Schmitz M; Villar-Piqué A; Hermann P; Escaramís G; Calero M; Chen C; Kruse N; Cramm M; Golanska E; Sikorska B; Liberski PP; Pocchiari M; Lange P; Stehmann C; Sarros S; Martí E; Baldeiras I; Santana I; Žáková D; Mitrová E; Dong XP; Collins S; Poleggi A; Ladogana A; Mollenhauer B; Kovacs GG; Geschwind MD; Sánchez-Valle R; Zerr I; Llorens F
Brain; 2022 Apr; 145(2):700-712. PubMed ID: 35288744
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases.
Thompson AGB; Anastasiadis P; Druyeh R; Whitworth I; Nayak A; Nihat A; Mok TH; Rudge P; Wadsworth JDF; Rohrer J; Schott JM; Heslegrave A; Zetterberg H; Collinge J; Jackson GS; Mead S
Mol Psychiatry; 2021 Oct; 26(10):5955-5966. PubMed ID: 33674752
[TBL] [Abstract][Full Text] [Related]
16. Characteristic CSF prion seeding efficiency in humans with prion diseases.
Cramm M; Schmitz M; Karch A; Zafar S; Varges D; Mitrova E; Schroeder B; Raeber A; Kuhn F; Zerr I
Mol Neurobiol; 2015 Feb; 51(1):396-405. PubMed ID: 24809690
[TBL] [Abstract][Full Text] [Related]
17. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
[TBL] [Abstract][Full Text] [Related]
18. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay.
Sano K; Satoh K; Atarashi R; Takashima H; Iwasaki Y; Yoshida M; Sanjo N; Murai H; Mizusawa H; Schmitz M; Zerr I; Kim YS; Nishida N
PLoS One; 2013; 8(1):e54915. PubMed ID: 23372790
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
[TBL] [Abstract][Full Text] [Related]
20. [CSF analysis of patients with prion disease by biomarkers and real-time qucking-induced conversion (RT-QUIC) method].
Satoh K
Rinsho Shinkeigaku; 2013; 23(11):1252-4. PubMed ID: 24291947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
